Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA448433
Max Phase: Preclinical
Molecular Formula: C22H28O3
Molecular Weight: 340.46
Molecule Type: Small molecule
Associated Items:
ID: ALA448433
Max Phase: Preclinical
Molecular Formula: C22H28O3
Molecular Weight: 340.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(/C=C/C(=O)/C=C/C2=C(C)CCCC2(C)C)cc1OC
Standard InChI: InChI=1S/C22H28O3/c1-16-7-6-14-22(2,3)19(16)12-11-18(23)10-8-17-9-13-20(24-4)21(15-17)25-5/h8-13,15H,6-7,14H2,1-5H3/b10-8+,12-11+
Standard InChI Key: HWDYWJZUBCLCOT-REVVXPLQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 340.46 | Molecular Weight (Monoisotopic): 340.2038 | AlogP: 5.37 | #Rotatable Bonds: 6 |
Polar Surface Area: 35.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.32 | CX LogD: 5.32 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.65 | Np Likeness Score: 1.11 |
1. Zhou J, Geng G, Batist G, Wu JH.. (2009) Syntheses and potential anti-prostate cancer activities of ionone-based chalcones., 19 (4): [PMID:19138519] [10.1016/j.bmcl.2008.12.089] |
2. Sharma V, Singh G, Kaur H, Saxena AK, Ishar MP.. (2012) Synthesis of β-ionone derived chalcones as potent antimicrobial agents., 22 (20): [PMID:22999415] [10.1016/j.bmcl.2012.08.084] |
3. Sharma V, Chaudhary A, Arora S, Saxena AK, Ishar MP.. (2013) β-Ionone derived chalcones as potent antiproliferative agents., 69 [PMID:24056146] [10.1016/j.ejmech.2013.08.017] |
Source(1):